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1. INTRODUCTION {#rmb212073-sec-0005}
===============

Male infertility is observed in \~50% of all infertile couples. Azoospermia is defined as an absence of sperm in ejaculated semen. According to the World Health Organization, azoospermia is observed in 10%‐15% of infertile men. An effective measure for azoospermia cases is testicular sperm extraction (TESE). The causes of azoospermia are obstructive azoospermia (OA), non‐obstructive azoospermia (NOA), including a lack of the azoospermia factor (AZF) c region, and Klinefelter syndrome (KS) and the possibility of pregnancy and birth could be increased by using TESE‐intracytoplasmic sperm injection (ICSI).[1](#rmb212073-bib-0001){ref-type="ref"}, [2](#rmb212073-bib-0002){ref-type="ref"}, [3](#rmb212073-bib-0003){ref-type="ref"}, [4](#rmb212073-bib-0004){ref-type="ref"}, [5](#rmb212073-bib-0005){ref-type="ref"} Men with male factor infertility have been treated successfully with ICSI and other additional methods, such as artificial oocyte activation, also have proven to be effective.[6](#rmb212073-bib-0006){ref-type="ref"}, [7](#rmb212073-bib-0007){ref-type="ref"} One effective technique for sperm retrieval that has been reported in a number of different studies is microdissection TESE (MD‐TESE), which is performed for NOA, and simple TESE that is performed for OA.[8](#rmb212073-bib-0008){ref-type="ref"}, [9](#rmb212073-bib-0009){ref-type="ref"} According to recent reports, blood hormone levels, follicle‐stimulating hormone (FSH), luteinizing hormone (LH), inhibin‐B, testosterone (T), testicular volume, Y chromosome microdeletion, and chromosome inspection are used as predictors in sperm retrieval.[10](#rmb212073-bib-0010){ref-type="ref"}, [11](#rmb212073-bib-0011){ref-type="ref"}, [12](#rmb212073-bib-0012){ref-type="ref"} After retrieval, one study reported a comparison between fresh and vitrified oocytes that were used in ICSI with fresh testicular sperm. The fresh oocytes had a higher FR than the vitrified oocytes.[13](#rmb212073-bib-0013){ref-type="ref"} However, there are various reports that indicate that fresh or frozen‐thawed sperm are useful to improve clinical outcomes.[14](#rmb212073-bib-0014){ref-type="ref"}, [15](#rmb212073-bib-0015){ref-type="ref"}, [16](#rmb212073-bib-0016){ref-type="ref"}, [17](#rmb212073-bib-0017){ref-type="ref"} Additionally, there are several reports on the influence of the maternal age factor.[15](#rmb212073-bib-0015){ref-type="ref"}, [18](#rmb212073-bib-0018){ref-type="ref"}, [19](#rmb212073-bib-0019){ref-type="ref"} This report is a retrospective, two‐center study. The aim was to find the best methods to achieve the highest pregnancy rates (PRs) and birth rates (BRs) for couples who need TESE‐ICSI.

2. MATERIALS and METHODS {#rmb212073-sec-0006}
========================

2.1. Patient population {#rmb212073-sec-0007}
-----------------------

From April, 1996 to July, 2016, 801 men with azoospermia or oligozoospermia underwent TESE in the authors' centers. Ultrasonography, clinical palpation, and clinical measurements of the testicular volume were performed. Hormonal assays, including serum FSH, LH, prolactin (PRL), and T, as well as karyotyping, were performed. The diagnoses were obtained from endocrine hormone levels (LH, FSH, PRL, and T) in the serum, chromosome karyotyping, clinical findings, and a semen analysis that was performed at least twice, which were confirmed by normal secondary sex characteristics. The cases with a testicular volume of both testes of \>12 mL and FSH levels of \<10 IU/mL were diagnosed as OA. The NOA cases included deletions of the AZFc region of the Y chromosome. The cases were classified into four groups: OA; NOA; KS; and Crypt.

Crypt was diagnosed in 58 cases; 272 were OA; and 388 were NOA. The NOA cases included 28 deletions of the AZFc region. There were 83 KS cases. Of the 737 ICSI cycles, 63 ICSI cycles were diagnosed as Crypt, 418 ICSI cycles as OA, 201 ICSI cycles as NOA, and 55 ICSI cycles were diagnosed as KS.

The various risks were explained in interviews and counseling. Written informed consent was obtained from all the patients who were involved in this study. Institutional review board approval was obtained from the local ethical committee.

2.2. Ovarian stimulation {#rmb212073-sec-0008}
------------------------

Ovarian stimulation was performed by using a combination of gonadotrophin‐releasing hormone (GnRH) agonist, FSH, and human menopausal gonadotrophin (hMG) or GnRH antagonist, FSH, hMG, and clomiphene citrate. An injection of 5000 IU of human chorionic gonadotrophin (hCG) and/or GnRH agonist was administered when the dominant follicle reached a mean diameter of 18 mm. A vaginal ultrasound‐guided follicular puncture was performed 36 hours after the hCG and/or GnRH agonist injection.

2.3. Sperm cryopreservation and thawing {#rmb212073-sec-0009}
---------------------------------------

The testicular sperm were mixed with sperm cryopreservation fluid (Sperm Freeze; Medi‐Con, Osaka, Japan) at a ratio of 1:0.7 before standing for 10 min. This then was exposed to liquid nitrogen (LN~2~) vapor for 15 min before being immersed in LN~2~ for storage.

When the sperm needed to be thawed, the frozen tube was warmed at room temperature for 10 s and placed directly into a 37**°**C water bath. Next, it was centrifuged with a hydroxyethyl piperazineethanesulfonic acid (HEPES)‐buffered medium. The pellet was suspended in 0.2 mL of the same medium (G‐MOPS; Vitrolife, Göteborg, Sweden) and then incubated at 37°C under 5% CO~2~ in air for 2‐3 hours.

2.4. Testicular sperm extraction and intracytoplasmic sperm injection {#rmb212073-sec-0010}
---------------------------------------------------------------------

Basically, TESE was timed to coincide with oocyte retrieval during controlled ovarian stimulation in each case. As long as there was a prospect of positive sperm retrieval, fresh TESE‐ICSI was performed in the first cycles and MD‐TESE was performed for NOA and simple TESE was performed for OA. In the OA cases, a simple TESE was performed at first. If no sperm were found, the switch was made to MD‐TESE. The biopsy was testicular tissue that had been placed in a dish filled with HEPES‐buffered medium (G‐MOPS; Vitrolife). The MD‐TESE was used, in which seminiferous tubules are directly examined throughout the testes by using an operating microscope and selectively biopsying for all of the patients as follows, in a modification of Schlegel\'s method.[20](#rmb212073-bib-0020){ref-type="ref"} The testicular tissue was minced with scissors in a dish and passed through a 21 gauge needle. After mincing, the tissue suspension was placed in a dish and covered with mineral oil. A microscope (×400) was used to check for sperm morphological quality and motility. An injection pipette was used to pick out the testicular sperm from the tissue suspension. The selected sperm were stored in a medium (Universal IVF; Origio, Copenhagen, Denmark).

The retrieved oocytes were cultured for 2‐3 hours in a medium (Universal IVF; Origio) at 37**°**C in an atmosphere of 6% CO~2~, 5% O~2~, and 89% N~2~ under humidified conditions and all the oocytes were denuded enzymatically with 40 IU/mL of hyaluronidase (Origio), followed by mechanical denudation. Subsequently, the oocytes were rinsed two‐to‐three times and cultured in fresh culture medium until ICSI.

The ICSI was performed by using fresh testicular sperm or frozen‐thawed testicular sperm. The injected oocytes were incubated in a culture medium under 6% CO~2~ and 5% O~2~ in air at 37**°**C. Normally, fertilized oocytes are defined as zygotes with two pronuclei (2PN) after ICSI. The clinical results using artificial oocyte activation were not included in this study.

2.5. Embryo transfer {#rmb212073-sec-0011}
--------------------

The observed 2PN and the top‐ or second‐quality embryos were selected. The morphological quality of the embryos was measured according to Veeck\'s and Gardner\'s criteria.[21](#rmb212073-bib-0021){ref-type="ref"}, [22](#rmb212073-bib-0022){ref-type="ref"} A single fresh embryo transfer was performed at day 2 or day 3 after oocyte retrieval. Fresh embryo transfer was avoided in cases with a risk of ovarian hyperstimulation syndrome or when the endometrial thickness was \<8 mm. In such cases, the blastocysts were vitrified and vitrified‐warmed embryo transfer was scheduled for a subsequent cycle. A single vitrified‐warmed blastocyst was transferred in either natural or hormone replacement therapy cycles. A clinical pregnancy was defined as pregnancy by observation of a gestational sac by a transvaginal ultrasound examination. The PRs were calculated per embryo transfer.

2.6. Fertilization rate, pregnancy rate, and birth rate {#rmb212073-sec-0012}
-------------------------------------------------------

The fertilization rate (FR), PR, and BR after ICSI were studied among three groups: fresh testicular sperm (FS)‐fresh oocytes (FO) (Group I); frozen‐thawed testicular sperm‐FO (Group II); and FS‐vitrified‐warmed oocytes (Group III).

2.7. Statistical analysis {#rmb212073-sec-0013}
-------------------------

The FRs were analyzed by the chi‐square test and the hormonal levels and age by the t test. All the statistical analyses were performed with State Mate v. 5.01 for Windows (ATMS, Inc., Tokyo, Japan). All *P*‐values of ≤.05 were considered to be statistically significant.

3. RESULTS {#rmb212073-sec-0014}
==========

3.1. Sperm retrieval {#rmb212073-sec-0015}
--------------------

Of the patients who underwent TESE, testicular sperm was retrieved successfully from 57.8% (463/801) of the patients. The retrieval rates in each group were as follows: 89.6% (52/58) for Crypt; 97.1% (264/272) for OA; 28.9% (112/388) for NOA; and 42.2% (35/83) for KS. The FSH levels were significantly higher in the NOA and KS groups, but the T levels were significantly lower in the KS group (Table [1](#rmb212073-tbl-0001){ref-type="table-wrap"}).

###### 

Clinical results of testicular sperm extraction (TESE)‐intracytoplasmic sperm injection (ICSI)

  Group                                                                                                                                                      Crypt         OA            NOA           KS            Total
  ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------- ------------- ------------- ------------- -------------
  Patients (N)                                                                                                                                               58            272           388           83            801
  Male age: y (mean ± SD)                                                                                                                                    38.7 ± 6.7    35.1 ± 6.5    35.5 ± 6.4    34.1 ± 4.9    35.5 ± 6.1
  Positive retrieval (%)[a](#rmb212073-note-0001){ref-type="fn"} ^,^ [b](#rmb212073-note-0001){ref-type="fn"} ^,^ [c](#rmb212073-note-0001){ref-type="fn"}   52 (89.6)     264 (97.1)    112 (28.9)    35 (42.2)     463 (57.8)
  LH (mIU/mL)[a](#rmb212073-note-0001){ref-type="fn"} ^,^ [b](#rmb212073-note-0001){ref-type="fn"} ^,^ [c](#rmb212073-note-0001){ref-type="fn"}              6.1 ± 3.8     4.1 ± 6.5     9.4 ± 7.4     18.6 ± 8.7    8.4 ± 7.5
  FSH (mIU/mL)[a](#rmb212073-note-0001){ref-type="fn"} ^,^ [b](#rmb212073-note-0001){ref-type="fn"} ^,^ [c](#rmb212073-note-0001){ref-type="fn"}             13.0 ± 10.1   6.1 ± 2.3     25.3 ± 15.9   36.8 ± 14.8   19.3 ± 16.5
  PRL (mIU/mL)                                                                                                                                               12.9 ± 8.3    10.6 ± 5.7    14.1 ± 9.9    10.1 ± 5.5    12.4 ± 8.3
  T (ng/mL) [a](#rmb212073-note-0001){ref-type="fn"} ^,^ [b](#rmb212073-note-0001){ref-type="fn"}                                                            4.9 ± 1.8     5.1 ± 4.3     4.5 ± 2.5     2.5 ± 1.6     4.5 ± 2.4
  No. of ICSI cycles                                                                                                                                         63            418           201           55            737
  Female age, y                                                                                                                                              37.2 ± 4.5    34.2 ± 6.3    34.1 ± 4.9    32.8 ± 4.0    34.6 ± 4.9
  No. of oocytes                                                                                                                                             367           2794          899           240           4300
  No. of zygotes (%)[a](#rmb212073-note-0001){ref-type="fn"} ^,^ [b](#rmb212073-note-0001){ref-type="fn"} ^,^ [c](#rmb212073-note-0001){ref-type="fn"}       218 (59.4)    1802 (64.5)   501 (55.7)    126 (52.5)    2647 (61.6)
  No. of transfers                                                                                                                                           85            589           197           50            921
  No. of pregnancies (%)                                                                                                                                     22 (25.9)     220 (37.3)    82 (41.6)     20 (40.0)     344 (37.4)
  No. of miscarriages (%)                                                                                                                                    3 (3.5)       44 (7.5)      21 (10.7)     3 (6.0)       71 (7.7)
  No. of live births (%)                                                                                                                                     14 (16.5)     147 (25.0)    43 (21.8)     14 (28.4)     218 (23.7)

Crypt, cryptozoospermia; FSH, follicle‐stimulating hormone; KS, Klinefelter syndrome; LH, luteinizing hormone; NOA, non‐obstructive azoospermia; OA, obstructive azoospermia; PRL, prolactin; SD, standard deviation; T, testosterone. ^a^ *P *\< .01: OA vs NOA; ^b^ *P *\< .01: OA vs KS; ^c^ *P *\< .05: OA vs Crypt.

John Wiley & Sons, Ltd

3.2. Hormonal levels {#rmb212073-sec-0016}
--------------------

The FSH and LH levels were significantly higher in the NOA and KS groups than in the OA group. The T levels were significantly lower in the KS group than in the OA group (Table [1](#rmb212073-tbl-0001){ref-type="table-wrap"}). The FSH and LH levels were significantly higher in the negative sperm retrieval group than in the positive group (*P*\<.001). The T level was lower in the negative sperm retrieval group than in the positive group (*P *= .009) (Table [2](#rmb212073-tbl-0002){ref-type="table-wrap"}).

###### 

Comparison of positive sperm retrieval and negative sperm retrieval

  Sperm retrieval               Positive      Negative      *P*‐value
  ----------------------------- ------------- ------------- -----------
  Patients (N)                  463           337           ---
  Male age, years (mean ± SD)   35.9 ± 7.3    34.5 ± 5.3    .006
  LH (mIU/mL)                   6.7 ± 5.5     10.7 ± 9.1    \<.001
  FSH (mIU/mL)                  13.8 ± 13.7   26.5 ± 17.2   \<.001
  PRL (mIU/mL)                  11.8 ± 7.8    13.2 ± 8.9    .406
  T (ng/mL)                     4.7 ± 2.4     4.3 ± 2.4     .009

FSH, follicle‐stimulating hormone; LH, luteinizing hormone; PRL, prolactin; SD, standard deviation; T, testosterone.

John Wiley & Sons, Ltd

3.3. Fertilization rate, pregnancy rate, and birth rate in cryptozoospermia, obstructive azoospermia, non‐obstructive azoospermia, and Klinefelter syndrome {#rmb212073-sec-0017}
-----------------------------------------------------------------------------------------------------------------------------------------------------------

The 424 couples who underwent 737 TESE‐ICSI cycles were studied. Their FR, PR, and BR levels were respectively 61.6%, 37.4%, and 23.7% in all patients; 59.4%, 25.9%, and 16.5% in the Crypt patients; 64.5%, 37.3%, and 25.0% in the OA patients; 55.7%, 41.6%, and 21.8% in the NOA patients; and 52.5%, 40.0%, and 28.4% in the KS patients (Table [1](#rmb212073-tbl-0001){ref-type="table-wrap"}).

3.4. Fertilization rate, pregnancy rate, and birth rate in Groups I‐III {#rmb212073-sec-0018}
-----------------------------------------------------------------------

The FR, PR, and BR were respectively 65.2%, 43.2%, and 28.5% in group I, 59.2%, 33.4%, and 18.7% in group II, and 56.4%, 33.8%, and 22.1% in group III. The PR and BR in group I was significantly higher than those of group II (*P* = .004 and *P *\< .001, respectively) (Table [3](#rmb212073-tbl-0003){ref-type="table-wrap"}).

###### 

Results after fresh oocytes were injected with fresh and frozen‐thawed testicular sperm

  Condition                                             Group                                                                                                
  ----------------------------------------------------- ------------------------------------------------- -------------------------------------------------- ------------
  Patients (N)                                          19                                                17                                                 ---
  No. of ICSI cycles                                    19                                                33                                                 10
  Female age, years (mean ± SD)                         35.5 ± 4.6                                        38.5 ± 4.0                                         36.5 ± 5.0
  No. of oocytes                                        159                                               169                                                33
  N (%) of zygotes                                      102 (64.2)                                        94 (55.6)                                          22 (66.7)
  No. of transfers                                      32                                                38                                                 8
  N (%) of pregnancies                                  8 (25.0)                                          11 (28.9)                                          3 (37.5)
  N (%) of miscarriages                                 1 (3.1)                                           0 (.0)                                             1 (12.5)
  N (%) of births                                       1 (3.1)[a](#rmb212073-note-0004){ref-type="fn"}   9 (23.7)[a](#rmb212073-note-0004){ref-type="fn"}   1 (12.5)
  [a](#rmb212073-note-0004){ref-type="fn"} *P *\< .05   ---                                                                                                  

  Obstructive azoospermia                                                                                   Group I: Fresh oocytes and fresh sperm                                                            Group II: Fresh oocytes and frozen‐thawed sperm      Group III: Frozen‐thawed oocytes and fresh sperm
  --------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------- ---------------------------------------------------- ----------------------------------------------------
  Patients (N)                                                                                              130                                                                                               113                                                  ---
  No. of ICSI cycles                                                                                        139                                                                                               237                                                  38
  Female age, years (mean ± SD)                                                                             32.1 ± 4.7                                                                                        36.1 ± 4.6                                           33.9 ± 4.8
  No. of oocytes                                                                                            1299                                                                                              1241                                                 250
  N (%) of zygotes                                                                                          878 (67.6)[a](#rmb212073-note-0004){ref-type="fn"}                                                775 (62.4)[a](#rmb212073-note-0004){ref-type="fn"}   148 (59.2)[b](#rmb212073-note-0005){ref-type="fn"}
  No. of transfers                                                                                          260                                                                                               280                                                  73
  N (%) of pregnancies                                                                                      115 (44.2)[a](#rmb212073-note-0004){ref-type="fn"} ^,^ [b](#rmb212073-note-0005){ref-type="fn"}   92 (32.9)[a](#rmb212073-note-0004){ref-type="fn"}    21 (28.8)[b](#rmb212073-note-0005){ref-type="fn"}
  N (%) of miscarriages                                                                                     25 (9.6)                                                                                          17 (6.1)                                             4 (5.5)
  N (%) of births                                                                                           82 (31.5)[a](#rmb212073-note-0004){ref-type="fn"}                                                 55 (19.6)[a](#rmb212073-note-0004){ref-type="fn"}    14 (19.1)[b](#rmb212073-note-0005){ref-type="fn"}
  [a](#rmb212073-note-0004){ref-type="fn"} *P*\<.01 and [b](#rmb212073-note-0005){ref-type="fn"} *P*\<.05   ---                                                                                               ---                                                  ---

  Non‐obstructive azoospermia                           Group I: Fresh oocytes and fresh sperm              Group II: Fresh oocytes and frozen‐thawed sperm     Group III: Frozen‐thawed oocytes and fresh sperm
  ----------------------------------------------------- --------------------------------------------------- --------------------------------------------------- --------------------------------------------------
  Patients (N)                                          68                                                  38                                                  ---
  No. of ICSI cycles                                    71                                                  78                                                  50
  Female age, years (mean ± SD)                         32.7 ± 4.6                                          35.7 ± 5.1                                          33.8 ± 4.2
  No. of oocytes                                        438                                                 367                                                 94
  N (%) of zygotes                                      260 (59.4)                                          193 (52.6)                                          48 (51.1)
  No. of transfers                                      73                                                  96                                                  40
  N (%) of pregnancies                                  36 (49.3)                                           33 (34.3)                                           15 (37.5)
  N (%) of miscarriages                                 8 (11.0)                                            10 (10.4)                                           3 (7.5)
  N (%) of births                                       23 (31.5)[a](#rmb212073-note-0004){ref-type="fn"}   12 (12.5)[a](#rmb212073-note-0004){ref-type="fn"}   9 (22.5)
  [a](#rmb212073-note-0004){ref-type="fn"} *P *\< .01   ---                                                 ---                                                 ---

  Klinefelter syndrome            Group I: Fresh oocytes and fresh sperm   Group II: Fresh oocytes and frozen‐thawed sperm   Group III: Frozen‐thawed oocytes and fresh sperm
  ------------------------------- ---------------------------------------- ------------------------------------------------- --------------------------------------------------
  Patients (N)                    19                                       14                                                ---
  No. of ICSI cycles              19                                       18                                                18
  Female age, years (mean ± SD)   32.1 ± 3.5                               33.4 ± 3.9                                        32.8 ± 4.3
  No. of oocytes                  77                                       100                                               63
  No. of zygotes (%)              46 (59.7)                                50 (50.0)                                         30 (47.6)
  No. of transfers                17                                       14                                                18
  N (%) of pregnancies            5 (29.4)                                 7 (50.0)                                          8 (44.4)
  N (%) of miscarriages           2 (11.8)                                 0 (.0)                                            1 (12.5)
  N (%) of births                 3 (17.6)                                 4 (28.6)                                          7 (38.9)

  Total                           Group I: Fresh oocytes and fresh sperm                Group II: Fresh oocytes and frozen‐thawed sperm       Group III: Frozen‐thawed oocytes and fresh sperm
  ------------------------------- ----------------------------------------------------- ----------------------------------------------------- --------------------------------------------------
  Patients (N)                    236                                                   182                                                   ---
  No. of ICSI cycles              248                                                   366                                                   116
  Female age, years (mean ± SD)   32.5 ± 4.7                                            36.1 ± 4.7                                            33.9 ± 4.6
  No. of oocytes                  1973                                                  1877                                                  440
  N (%) of zygotes (%)            1286 (65.2)[a](#rmb212073-note-0004){ref-type="fn"}   1112 (59.2)[a](#rmb212073-note-0004){ref-type="fn"}   248 (56.4)
  No. of transfers                382                                                   428                                                   139
  N (%) of pregnancies (%)        165 (43.2)[a](#rmb212073-note-0004){ref-type="fn"}    143 (33.4)[a](#rmb212073-note-0004){ref-type="fn"}    47 (33.8)
  N (%) of miscarriages           36 (9.4)                                              27 (6.3)                                              9 (6.5)
  N (%) of births                 109 (28.5)[a](#rmb212073-note-0004){ref-type="fn"}    80 (18.6)[a](#rmb212073-note-0004){ref-type="fn"}     31 (22.1)

SD, standard deviation.

*P*\<.01.

*P*\<.05.

John Wiley & Sons, Ltd

4. DISCUSSION {#rmb212073-sec-0019}
=============

This study analyzed the clinical results of TESE since 1996. First were investigated the sex and pituitary hormone levels in the male positive sperm retrieval and negative sperm retrieval groups. The sperm retrieval rate was 57.8% of the total; however, the result that FSH and LH were higher in the sperm‐negative cases simply reflects the fact that they are usually higher in a NOA cohort, compared to an OA cohort and OA cases were a large proportion of all the cases in this study. This is related to an accidental bias and there is no locality. In the current results, the FSH and LH hormone levels were significantly higher in the negative sperm retrieval group than in the positive group. The T levels were lower in the negative sperm retrieval group than in the positive group. Spermatogenic function of the testis needs to be suitable in various sex hormone parameters. Recent reports of the predictive factor of sperm retrieval investigated FSH, LH, inhibin‐B, and T.[10](#rmb212073-bib-0010){ref-type="ref"}, [11](#rmb212073-bib-0011){ref-type="ref"} In many cases of high FSH levels, there is a high possibility that sperm retrieval will fail. The FSH levels are considered to be useful as a predictor. However, according to one report, men with maturation arrest have normal serum FSH levels ( ≤ 7.6 IU/mL). These patients with spermatozoa with maturation arrest had a higher frequency of genetic anomalies, compared to NOA patients.[23](#rmb212073-bib-0023){ref-type="ref"} Male age also is considered to be a predictive factor in KS cases.[5](#rmb212073-bib-0005){ref-type="ref"}, [24](#rmb212073-bib-0024){ref-type="ref"} The hormonal level indication is not intended to set the criteria for the positive or negative result of sperm retrieval; it is important to comprehend the patient\'s background by receiving adequate patient information prior to surgery.

Comparing fresh TESE‐ICSI and frozen‐thawed TESE‐ICSI injected with fresh oocytes, the factors of female age, FRs, and clinical PRs of the fresh TESE‐ICSI group were significantly higher than in the frozen‐thawed TESE‐ICSI group. A couple of reports found that female age factors did not influence TESE‐ICSI in each case.[15](#rmb212073-bib-0015){ref-type="ref"}, [19](#rmb212073-bib-0019){ref-type="ref"} In previous reports, FRs were lower in older women.[18](#rmb212073-bib-0018){ref-type="ref"} However, they did not compare fresh sperm with frozen‐thawed sperm.[16](#rmb212073-bib-0016){ref-type="ref"}, [17](#rmb212073-bib-0017){ref-type="ref"}

There are various reports on the aneuploidy of sperm.[25](#rmb212073-bib-0025){ref-type="ref"}, [26](#rmb212073-bib-0026){ref-type="ref"} The assessment of testicular function and sperm quality is related to varicocele,[27](#rmb212073-bib-0027){ref-type="ref"}, [28](#rmb212073-bib-0028){ref-type="ref"}, [29](#rmb212073-bib-0029){ref-type="ref"}, [30](#rmb212073-bib-0030){ref-type="ref"} aging,[31](#rmb212073-bib-0031){ref-type="ref"}, [32](#rmb212073-bib-0032){ref-type="ref"}, [33](#rmb212073-bib-0033){ref-type="ref"}, [34](#rmb212073-bib-0034){ref-type="ref"}, [35](#rmb212073-bib-0035){ref-type="ref"} and freezing‐thawing. Male aging does not influence testicular sperm specifically.[35](#rmb212073-bib-0035){ref-type="ref"} However, the sperm recovery rate decreases according to men\'s age in KS, so men\'s age should be considered.[36](#rmb212073-bib-0036){ref-type="ref"} Freezing‐thawing of sperm in assisted reproductive technology (ART) is an important technique.

Freezing and thawing is an important technique in ART, although it is difficult to avoid damage to cryopreserved sperm in the freezing and thawing process. It is known to result in sperm DNA fragmentation[37](#rmb212073-bib-0037){ref-type="ref"}, [38](#rmb212073-bib-0038){ref-type="ref"} and decreased motility and mitochondrial function.[39](#rmb212073-bib-0039){ref-type="ref"} DNA damage is correlated with the period of gestation after embryo transfer. The abnormality of sperm chromatin also affects the growth after implantation and has a negative effect on pregnancy loss.[40](#rmb212073-bib-0040){ref-type="ref"}, [41](#rmb212073-bib-0041){ref-type="ref"} Sperm cryopreservation and in vitro incubation are related to DNA integrity of the testicular sperm.[42](#rmb212073-bib-0042){ref-type="ref"} The PR has been shown to be significantly lower in the frozen‐thawed TESE‐ICSI group than in the fresh TESE‐ICSI group.[43](#rmb212073-bib-0043){ref-type="ref"} This study found that fresh TESE‐ICSI in the OA group showed significantly higher FRs and PRs than cryopreserved testicular sperm, though this was not the case in the NOA group. The current authors could not identify the causes. There might be cases that are sensitive to freezing damage. The authors would like to investigate this as a subject of analysis. In ICSI, morphologically normal sperm are selected as much as possible, focusing on the lack of observable DNA and the structural integrity of normal sperm under a bright field. Therefore, it is desirable to avoid sperm damage.

There is no guarantee, depending on the case, that TESE can provide sufficient sperm retrieval after surgery. In cases of low sperm counts, other methods, such as the cryoloop and empty zona methods could be used for cryopreservation. However, these methods are not useful for cryopreserving a few sperm in clinical practice.[44](#rmb212073-bib-0044){ref-type="ref"} In this study, the FRs and PRs were not significantly different. However, a study also reported cases with small numbers of recovered sperm in non‐mosaic KS cases, with the result that non‐pregnant couples obtained only a few immotile sperm following the freezing‐thawing procedure. For such cases, fresh TESE‐ICSI should be considered first.[5](#rmb212073-bib-0005){ref-type="ref"} In particular, it is very difficult to cryopreserve in NOA and KS cases with few sperm that lack motility and have severe DNA damage (eg, hypospermatogenesis cases). In Crypt cases, semen cryopreservation before TESE also might be an alternative for cases that are expected to have low probabilities of obtaining fresh sperm at the time of egg retrieval.

As there are \~50 urology specialists in Japan, it is very difficult for full‐time special urologists to perform TESE in \~600 ART centers every day. Thus, in the authors' two centers, two part‐time special urologists perform TESE one day per week realistically. There have been good results following ICSI with fresh testicular sperm and vitrified warmed oocytes.[13](#rmb212073-bib-0013){ref-type="ref"} In conclusion, this study\'s results suggest that fresh testicular sperm have a high developmental potential, compared to frozen‐thawed testicular sperm.

The authors recommend the use of fresh oocytes with fresh testicular sperm as the first‐choice treatment. The second‐choice treatment would be vitrified‐warmed oocytes with fresh testicular sperm or fresh oocytes with frozen‐thawed testicular sperm, depending on the couple\'s opinion. It is important to understand the background of each patient and to select the treatment strategies accordingly.
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